The objective is to improve and maintain the antiviral treatment efficacy of lamivudine in chronic hepatitis B.

Other investigators have considered the addition of a third antibiotic to the regimen to increase treatment efficacy.

Both groups were compared after 6 weeks of treatment efficacy, lesion area score, lesion severity score and the security situation.